כל המחקרים
גיוסשלב 4התערבותי

Staphylococcus Aureus Network Adaptive Platform Trial

The SNAP trial is looking into better ways to treat a serious blood infection caused by a germ called Staphylococcus aureus (S. aureus), also known as SAB. This infection can be very dangerous, and sadly, some people don't survive. Doctors currently use different ways to treat it, but aren't sure which is most effective. This study will test several existing treatments to see which ones save the most lives within 90 days. Unlike traditional studies, SNAP can change as it goes along, focusing more on treatments that seem to work better and removing those that don't. This helps ensure patients receive the most promising care and helps doctors quickly learn the best ways to treat this infection.

במבט חטוף

סטטוס
גיוס
שלב
שלב 4
נותן חסות
University of Melbourne
יעד הרשמה
8,000
התחל
16 Feb 2022
השלמה משוערת
01 דצמבר 2028

על מה המחקר הזה?

The Staphylococcus aureus Network Adaptive Platform (SNAP) trial is a really important study looking for better ways to treat a serious blood infection. This infection is caused by a germ called Staphylococcus aureus, which doctors often shorten to S. aureus or SAB. When S. aureus gets into your bloodstream, it can be very dangerous and can lead to serious health problems, and sadly, some patients don't survive.

Currently, there are several ways doctors treat S. aureus blood infections, but they don't have a clear idea of which treatment plan is the best. The SNAP trial wants to change that. It's designed to compare different treatments to find out which ones lead to the best results, specifically looking at which treatments help the most patients survive the first 90 days after getting the infection.

What's special about the SNAP trial is that it's 'adaptive.' This means that as the study goes on and doctors learn more about which treatments are working better, they can adjust the trial. They can give more patients the treatments that seem more effective and stop using treatments that aren't working as well. They can also add new treatments if they look promising. This smart approach helps ensure that patients in the trial get the best possible care based on the latest information, and it helps doctors quickly figure out the most effective ways to fight this infection.

נקודות עיקריות

  • The SNAP trial studies treatments for a serious blood infection (S. aureus).
  • It aims to find the best treatments to improve survival.
  • The study is 'adaptive', meaning it learns and adjusts as it goes.
  • All treatments are existing medicines, not experimental ones.
  • Participation could help uncover better future treatments for this infection.

מי עשוי להיות זכאי?

To join the main part of this study, you would need to have a Staphylococcus aureus germ found in at least one of your blood tests. You also need to be a patient in a hospital taking part in the study. If you've sadly passed away, but were in a participating hospital when your blood sample was taken, your medical information might still be included in the study.

However, there are reasons why you might not be able to join. For example, if it's been more than 72 hours (3 days) since your blood test was taken, or if other germs are found in your blood at the same time as S. aureus. You also can't join if you've already been part of this specific trial before, or if your medical team feels that joining wouldn't be in your best interest due to other serious health concerns or if you are receiving end-of-life care. Patients under 18 years old can only join if the hospital has special approval for younger patients.

האם מחקר זה יכול להתאים לך?

ענה על השאלות המהירות הללו כדי לבדוק אם אתה עשוי להיות זכאי. זהו מדריך בלבד — צוות המחקר מקבל את ההחלטה הסופית.

  1. Do you have Staphylococcus aureus found in your blood?
  2. Are you currently an inpatient at a hospital participating in this study?
  3. Is it less than 3 days since your blood sample was taken?
  4. Do you have only S. aureus in your blood, and no other serious infections there?
  5. Are you aged 18 or over (unless your hospital has approval for younger patients)?
ענה על כל שאלה כדי לראות את התוצאה שלך.

מה כרוך בהשתתפות?

If you are asked to join the SNAP trial, you'll be assigned by chance to one of the different treatment groups. These treatments are all ones that doctors already use. You'll receive your antibiotics, likely through an drip into your vein while you're in the hospital. The study team will closely monitor your health and recovery while you are receiving treatment and thereafter. They will review your medical information to see how well the treatment is working. The SNAP trial aims to find the most effective treatments for S. aureus blood infections to improve patient outcomes.

סיכונים ותועלות פוטנציאליים

Taking part in this study could help doctors learn which treatments for S. aureus blood infections are most effective, potentially helping you and many future patients. All treatments used are already part of standard medical care, so you wouldn't be receiving an experimental drug. However, as with any medical treatment, there can be side effects, and your doctor will discuss these with you. You are free to withdraw from the study at any time without it affecting your medical care.

Locations (161)

  • Houston Methodist Research Institute
    מיקוד מאומת
    יוסטון, ארצות הברית· גיוס
  • Canberra Hospital
    מיקוד מאומת
    Garran, Australia· גיוס
  • Blacktown Hospital
    מיקוד מאומת
    בלקטאון, אוסטרליה· גיוס
  • Royal Prince Alfred Hospital
    מיקוד מאומת
    קמפרדאון, אוסטרליה· גיוס
  • Concord Repatriation and General Hospital
    מיקוד מאומת
    Concord, Australia· גיוס
  • St Vincent's Hospital Sydney
    מיקוד מאומת
    Darlinghurst, Australia· גיוס
  • Nepean Hospital
    מיקוד מאומת
    Kingswood, Australia· גיוס
  • St George Hospital
    מיקוד מאומת
    Kogarah, Australia· עדיין לא מגייסים
  • Liverpool Hospital
    מיקוד מאומת
    ליברפול, אוסטרליה· גיוס
  • John Hunter Hospital
    מיקוד מאומת
    New Lambton Heights, Australia· גיוס
  • John Hunter Children's Hospital
    מיקוד מאומת
    Newcastle, Australia· גיוס
  • Orange Health Service
    מיקוד מאומת
    Orange, Australia· גיוס

שאלות נפוצות

What is Staphylococcus aureus (S. aureus) blood infection?

It's a serious infection where a common germ called Staphylococcus aureus gets into your bloodstream. It can make you very unwell.

What does 'adaptive platform trial' mean?

It's a smart study design that can change as it goes along. Doctors can learn from early results and focus more on treatments that are working best, or remove those that aren't.

Will I get a new or experimental medicine?

No, all the treatments being tested in this study are medicines already used by doctors. The study is comparing them to find out which works best.

כמה זמן אהיה במחקר?

The study will look at how you are doing for 90 days after your infection. Your medical team will monitor you during this time.

Can I choose my treatment?

No, if you join, you will be randomly assigned to one of the established treatment options. This helps ensure fair testing of each treatment.

כיצד לגלות עוד

Lauren Barina

תמיד התייעץ עם רופא המשפחה או המומחה שלך לפני שתחליט להשתתף במחקר.

מעוניינים להשתתף?

רשום את התעניינותך

שתף את הפרטים שלך וצוות המחקר עבור "Staphylococcus Aureus Network Adaptive Platform Trial…" ייצרו איתך קשר אם אתה עשוי להיות זכאי. תמיד התייעץ עם הרופא שלך לפני שאתה מסכים להשתתף.

דיון

דיון קהילתי

מופעל על ידי הפורום שלנו ב community.patient.info. אנא היו מכבדים — זה אינו ייעוץ רפואי.